Merck & Co., Inc. (MRK)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Industry: Pharmaceutical Preparations (SIC 2834)

Market region: US

Address: 126 East Lincoln Avenue, P.o. Box 2000, Rahway, NJ, 07065

Market capitalization

368.89 billion USD (368,891,503,314 USD)

Listing date

04/20/1949

Weighted shares outstanding

2,467,171,638

Share class shares outstanding

2,467,171,638

https://www.merck.com